Smartphone-based Financial Incentives for Smoking Cessation

University of Vermont, Burlington, VT

Targeting 2 different conditionsSmartphone-based Financial Incentives +1 moreN/ARecruitingLed by Diann Gaalema, PhDResearch Sponsored by University of Vermont

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

self-report as an Alaska Native

own a smartphone (Android or iOS)

Must not have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upone month after participant's enrollment date

Awards & highlights

No Placebo-Only Group

Study Summary

This trial will test the feasibility and effectiveness of a smartphone-based financial incentives intervention to help Alaska Native pregnant women quit smoking.

Eligible Conditions

Smoking Cessation
Smoking

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You identify yourself as an Alaska Native.

Select...

You have a smartphone that runs either Android or iOS operating system.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one month after participant's enrollment date

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one month after participant's enrollment date

This trial's timeline: 3 weeks for screening, Varies for treatment, and one month after participant's enrollment date for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Late Pregnancy Quit Rate

Secondary outcome measures

12-Week Postpartum Quit Rate

24-Week Postpartum Quit Rate

4-Week Postpartum Quit Rate

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Best Practices + Incentives groupExperimental Treatment2 Interventions

Participants assigned to this condition will receive the best practices treatment plus the financial incentives intervention.

Group II: Best PracticesActive Control1 Intervention

Participants assigned to this condition will receive the best practices treatment alone.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Best Practices

2015

N/A

~200

0 / 2Eligibility criteria met

Find a site

Who is running the clinical trial?

Mayo ClinicOTHER

3,048 Previous Clinical Trials

3,484,823 Total Patients Enrolled

University of VermontLead Sponsor

258 Previous Clinical Trials

3,741,710 Total Patients Enrolled

Alaska Native Tribal Health ConsortiumOTHER

13 Previous Clinical Trials

7,770 Total Patients Enrolled

Diann Gaalema, PhDPrincipal Investigator

University of Vermont

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can people with the qualifying condition enroll in this research project at this time?

"Yes, the information available on clinicaltrials.gov indicates that this trial is presently recruiting patients. The trial was first announced on December 15th, 2021 and was most recently updated on June 9th, 2022. The study needs to enroll 60 patients from a single site."

Answered by AI